Product Details
Additional Information
| Product Name | Saphnelo (anifrolumab) Injection, 150 mg/mL, 2 mL Vial |
| Manufacturer | -- |
| Generic/Active Ingredient | Anifrolumab |
| Route of Administration | Intravenous |
| Dose Form | Parenteral preparations |
| Strength | 150 mg / 1 mL |
| Container Type | Box, Vials |
| Volume | 2 mL |
| Mechanism of Action | Anifrolumab binds to the type I interferon receptor subunit and blocks type I interferon signaling. |
| Application | Immunosuppressive Biologic |
| Side Effects | Adverse events include infections, infusion-related reactions, hypersensitivity reactions, headache, nausea, vomiting, fatigue, dizziness, cough, arthralgia, and malignancy. |
| Storage | Discard product if it contains particulate matter, is cloudy, or discolored. Discard unused portion. Do not store for later use. Do not freeze. Do Not Shake. If infusion solution is not administered immediately, store diluted solution at room temperature (59°F to 77°F, 15°C to 25°C) for up to 4 hours. If infusion solution is not administered immediately, store diluted solution refrigerated (36°F to 46°F, 2°C to 8°C) for up to 24 hours. Refrigerated product should reach room temperature before administration. Store in refrigerator at 2°C to 8°C (36°F to 46°F). Store in the original carton to protect from light. |
This description is for informational purposes only and is not clinical advice.
Frequently Asked Questions (FAQs)
The cost of SAPHNELO SF 150MG/ML 2ML is $available for registerd members only
SAPHNELO SF 150MG/ML 2ML is manufactured by --.
You can purchase SAPHNELO SF 150MG/ML 2ML on our website at https://supplies.pipelinemedical.com/product/detail/saphnelo-sf-150mg-ml-2ml-640960